[Artificial intelligence and palliative care: opportunities and limitations.]

Intelligenza artificiale e cure palliative: opportunità e limiti.

Journal

Recenti progressi in medicina
ISSN: 2038-1840
Titre abrégé: Recenti Prog Med
Pays: Italy
ID NLM: 0401271

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 20 4 2022
Statut: ppublish

Résumé

The so-called artificial intelligence tools applied to palliative care (machine learning, natural language processing) have great potential to support clinicians in improving decision-making processes and in identifying those who are at high risk of mortality or at greater risk of inappropriate treatment and/or non-positive outcomes. The improvement of prognostic abilities may help to avoid that some choices of patients with serious diseases are taken only in the last days of life, in the face of treatment options not previously discussed in an adequate and shared way. These tools can facilitate some essential aspects in the practice of palliative care, for example the activation of interviews that have as their objective the advance care planning and the definition of treatments consistent with the needs and desires of patients, especially in final stages of life. The development, also in our country, of projects for the application of artificial intelligence in palliative care requires particular attention to the possible organizational repercussions and to some ethical and relational aspects. It will be necessary to reflect on the most appropriate organizational models and on the specialized resources necessary in relation to the foreseeable increase in the number and variability of patients with early identified palliative care needs. These tools must not interfere in fundamental elements of the relationship between patient and doctor, that is the ability to communicate a poor prognosis in an individualized and ethically appropriate way.

Identifiants

pubmed: 33205761
doi: 10.1701/3474.34564
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

639-645

Auteurs

Carlo Peruselli (C)

Past President Società Italiana Cure Palliative (SICP).

Ludovica De Panfilis (L)

Unitàdi Bioetica, Azienda USL-IRCCS di Reggio Emilia.

Gino Gobber (G)

UOM Cure Palliative, Azienda Provinciale per i Servizi Sanitari, Trento.

Massimo Melo (M)

UOM Cure Palliative, Azienda Provinciale per i Servizi Sanitari, Trento.

Silvia Tanzi (S)

Unità di Cure Palliative, Azienda USL-IRCCS di Reggio Emilia, Clinical and Experimental Medicine PhD Program, Università di Modena e Reggio Emilia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH